K&L Gates Healthcare Triage

340B Drug Pricing Program: Rebate Model Considerations


Listen Later

In this episode, Gabriel Scott, Mark Ogunsusi, and Amanda Smith take a focused look at the 340B Drug Pricing Program, with particular attention to recent developments related to proposals for a 340B rebate model. They discuss why stakeholders may support or oppose a rebate‑based approach to 340B pricing and highlight key considerations relating to such a model.

...more
View all episodesView all episodes
Download on the App Store

K&L Gates Healthcare TriageBy K&L Gates LLP

  • 4
  • 4
  • 4
  • 4
  • 4

4

10 ratings